ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹286 Cr | ₹260 Cr | ₹372 Cr | ₹241 Cr | ₹142 Cr |
What is the latest Total Current Liabilities ratio of ORCHID PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹286 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹372 Cr |
| Mar2022 | ₹241 Cr |
| Mar2021 | ₹142 Cr |
How is Total Current Liabilities of ORCHID PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹286 Cr | 9.85 | |
| Mar2024 | ₹260 Cr | -30.09 | |
| Mar2023 | ₹372 Cr | 54.45 | |
| Mar2022 | ₹241 Cr | 69.46 | |
| Mar2021 | ₹142 Cr | - | |
Compare Total Current Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,041.0 Cr | -7.1% | -12.8% | -35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -7.1% |
-12.8% |
-35.8% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses